MK-1026-003

A Phase 2/3 Relapsed and/or Refractory Multiple Myeloma study

Enquire

Trial overview

Disease

Haematology

Topic

MK-1026

Sponsor

MSD

Description

A Phase 2/3, Randomized, Open-Label Study Comparing Oral Ixazomib/Dexamethasone and Oral Pomalidomide/Dexamethasone in Relapsed and/or Refractory Multiple Myeloma

Study details

For detailed information on this trial, please click here.

Trial status

Recruiting

Location

Oxford

Windsor

Cambridge

Priniciple Investigator

Dr Jaimal Kothari

MA, BM BCh, MRCP, FRCPath

Haematologist

Oxford +1

Professor George Follows

MA, BM BCh (Oxon), PhD, FRCP, FRCPath

Consultant haematologist